Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
Researching herpes treatments with 'skin-on-chip' technology
Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
Researchers refine experimental gene therapy for herpes
Treatment sharply reduced viral shedding in laboratory mice
What viruses can teach us about ourselves
Dr. Daphne Avgousti studies viruses that can give us a window into fundamental human biology that we can use to improve our health
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
Tissue localization shapes antiviral T cell dynamics
From the Prlic and Lund labs, Vaccine and Infectious Disease Division
B cell kinetics during HSV-2 infection
From the Corey lab, Vaccine and Infectious Disease Division
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
A cure for herpes? There is progress to report
Mouse studies show gene therapy can cause big drop in latent infections
¿La cura del herpes? Hay avances que reportar
Los estudios con ratones muestran que la terapia génica puede reducir muchísimo las infecciones inactivas
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Inflammatory mucosal T cells: harmful or helpful?
From the Lund lab, Vaccine and Infectious Disease Division
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Dr. Joshua Hill receives Amy Strelzer Manasevit grant award
Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections
Stealing a secret from an unwelcome virus
An unexpected discovery in a herpes lab might bring relief to cancer patients
Experimental herpes drug pritelivir more effective than standard treatment
Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows
Can gene editing cure herpes?
Fred Hutch study shows ‘pathway to potential cure’ for herpes simplex and other latent viruses
‘I pray that God will help me’: Treating Kaposi sarcoma in Uganda
Researchers are partnering to better understand infection-related cancers
Cancer care’s unlikely advocate
When his daughter falls ill, a traditional healer in Uganda seeks a Western cure
Halting herpes' transmission
New Hutch study predicts threshold of viral load for passing herpes from one person to another
Genital herpes-suppressing immune cells identified
Discovery by Fred Hutchinson Cancer Research Center’s Dr. Larry Corey and colleagues has implications for development of vaccine to prevent and treat HSV-2, similar infections